---
layout: post
title: "Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising"
date: 2026-02-05 18:55:19 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-08686
original_published: 2023-04-25 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** April 25, 2023 00:00 UTC
**Document Number:** 2023-08686

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on the proposed study entitled "A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising."

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/04/25/2023-08686/agency-information-collection-activities-proposed-collection-comment-request-a-survey-on)
- API: https://www.federalregister.gov/api/v1/documents/2023-08686

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
